Aim: Defining the relationship between early markers of atherosclerosis and the level of total cardiovascular risk (CVR) in a cohort of men. Materials and methods: The study included 200 men aged 40-55 years with different levels of CVR without clinical manifestations of CVD. The total CVR was defined by the SCORE. Patients were divided into three groups: low and moderate risk <5%, the highest risk 10.5% and very high risk > 10%.
Plasma lipoprotein profile is one of the major factors to describe the risk of atherosclerotic cardiovascular disease. The exact mechanisms for development and progression of atherosclerosis in subjects with coronary artery disease (CAD) although having higher HDL-C levels are still unknown. To reveal the role of HDL subclasses, apolipoproteins and CETP activity and mass levels in the atherosclerotic process is very important for these subjects. The aim of our study was comparing the levels of HDL subclasses, apolipoproteins, CETP mass and activity between the patients with coronary artery disease and healthy subjects, although having higher HDL-C levels.
Between November 2011 and July 2012 35 patients who have coronary artery disease and HDL-C levels !60 mg/dl, LDL-C levels !130 mg/dl, and 35 healthy subjects with the same lipid profile who admitted Gazi University Cardiology Department, enrolled for this study. The CETP mass and activity, apo A1, apo A2, apo B, HDL 2 and HDL 3 levels of the patients and control subjects were measured.
Therewerenosignificant differences on apo A2, apo B, HDL 2 and HDL 3 levels between the patients with CAD and control subjects. Apo A1 levels were higher in patients with CAD (mean 588,6 mg/ml vs 414 mg/ml, p¼0,006). Although CETP mass was not different (mean 27,7 mg/ml vs 24,2 mg/ml, p¼0,27), in both groups, CETP activity was significantly higher (mean 1,08 nmol/ml plasma/1 hour vs 0,98 nmol/ml plasma/1 hour, p¼0,007) in CAD positive group.
In this special study population which contains subjects with or without CAD and have higher HDL-C and LDL-C levels, the findings showed that plasma CETP activity was higher in patients than control subjects whereas CETP mass, HDL subclasses, apo B and apo A2 levels were similar in cases versus controls. But unexpectedly and interestingly apo A1 levels were higher in patients with CAD.
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Xanthelasma is Associated with Increased Amount of Epicardial Adipose Tissue Background: Appraisal of certain cutaneous markers linked to coronary artery disease may help clinician to suspect disease in the subclinical phase. Xanthelasma palpebrum is a common cutaneous sign which was shown to predict the risk of ischemic heart disease in general population, independently of well known cardiovascular risk factors. Increased amount of epicardial adipose tissue, which is considered as visceral fat of heart, was shown to promote coronary atherosclerosis through local paracrine effects, in addition to associated systemic inflammation. Aım: In the present study, we aimed to compare the amount of epicardial adipose tissue in subjects with and without xanthelasma. Methods: Consecutive 52 patients with xanthelasma and age-gender matched 48 control subjects were enrolled. Epicardial adipose tissue was assessed by measuring epicardial fat thickness (EFT) by echocardiography. Data were collected concerning coronary artery disease risk factors by clinical history, and blood chemistry. Results: Subjects with xanthelasma had higher body mass index (BMI) (31.3AE5.8 vs.
28.0AE5.9, p¼0.008), and higher levels of total cholesterol (218AE55 mg/dl vs. 172 AE 34 mg/dl, p<0.001), LDL-c (144AE46 mg/dl vs. 111AE32 mg/dl, p<0.001), and triglyceride (median 154 mg/dl vs. 110 mg/dl, p<0.001) compared to control subjects (Table 1) . Other risk factors and HDL-c levels were similar in both groups. Median EFT was 4 mm in the study population. Epicardial fat thickness was significantly higher in subjects with xanthelasma as compared to controls (5.0AE2.0 vs. 3.1AE1.8, p<0.001). Binary logistic regression analysis was performed to find the independent factors associated with supramedian epicardial fat thickness (EFT>4 mm). In this model, presence of xanthelasma (OR, 27.1; 95% CI, 4.4-168.3, p<0.001) and triglyceride level (OR, 1.02; 95% CI, 1.00-1.03, p < 0.021) were found to be independently associated with supramedian EFT (Table 2) . Conclusıon: In the present study, we found higher amount of epicardial adipose tissue in subjects with xanthelasma. In addition, presence of xanthelasma was found to be independently associated with supramedian EFT. 
